Juno is pleased to announce the launch of their new range of polypropylene pre-filled syringes, supplied by Aguettant, a leading French manufacturer of injectable medicines.

Established in Lyon in 1903, Aguettant remains an independent, family owned company, while growing to have three sites across France and a presence in over 60 countries.

Juno has partnered with Aguettant to supply a number of life-saving medicines to the Australian market. Registered products in the pre-filled syringe range currently include:

• ADRENALINE AGUETTANT 1:10,000 adrenaline (epinephrine) (as acid tartrate) 1 mg/10 mL solution for injection prefilled syringe
• EPHEDRINE AGUETTANT ephedrine hydrochloride 30 mg/10 mL solution for injection pre-filled syringe

Additional products supplied to Juno by Aguettant include:

• SODIUM VALPROATE JUNO sodium valproate 400 mg/4 mL solution for injection, ampoule

This new commercial agreement and range is in line with Juno’s vision to lead the category by improving the way products are developed and delivered to market.

For more information on the new range, please get in touch:

General public: Contact our medical information team
P: 1800 620 076 E: medical-enquiries@junopharm.com.au

Healthcare professionals: Contact your local key account manager

Roz Pelen – VIC/TAS
M: 0417 720 821 E: roz.pelen@junopharm.com.au

Majella McCann – SA/WA/NT
M: 0447 005 868 E: majella.mccann@junopharm.com.au

Jacqui Swan – QLD
M: 0447 575 708 E: jacqui.swan@junopharm.com.au

Mary Abdelmalek – NSW/ACT
M: 0437 053 505 E: mary.abdelmalek@junopharm.com.au

Anita Butko – National
M: 0475426004 E: anita.butko@junopharm.com.au

Med199. Prepared July 2018.